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A B S T R A C T
Background: Estrogens and phytoestrogens can hinder the aging process through mechanisms related to
estrogen receptors (ERs), guanine nucleotide-binding protein-coupled receptor (GPER30), mitochondria
function and nitric oxide (NO) release. Up to date, however, the above issues are a matter of debate.
Objective: To examine the effects elicited by 17 β-estradiol and genistein against peroxidation in human
keratinocytes/fibroblasts and evaluate the role played by ERs, GPER30, mitochondria and NO.
Methods: Human fibroblasts/keratinocytes, either subjected to peroxidation or not, were exposed to 17 β-
estradiol/genistein in the absence or presence of the NO synthase (NOS) inhibitor, the ERs and GPER30
blockers, fulvestrant and G15, the phosphatidyl-inositol-3-kinase (PI3K-Akt), the p38 mitogen-activated
protein (MAP) kinase and the extracellular signal–regulated kinases (ERK) 1/2 inhibitors. Specific kits
were used for cell viability, NO, ROS and glutathione (GSH) detection and mitochondrial membrane
potential measurement. Western Blot analysis was performed for kinases expression/activation
detection.
Results: In physiological and peroxidative conditions, 17 β-estradiol/genistein respectively increased and
reduced NO release by fibroblasts/keratinocytes. Moreover, both agents prevented the ROS release and
the fall of cell viability and mitochondrial membrane potential, while increasing GSH levels and the
proliferation rate. Fulvestrant and G15 counteracted all above responses. Also, the NOS, and the kinases
blockers reduced the protection exerted by 17 β-estradiol/genistein on cell viability/mitochondria
function. The involvement of PI3K-Akt and p38-MAPK was confirmed by Western blot.
Conclusion: 17 β-estradiol/genistein protected fibroblasts/keratinocytes against peroxidation by
modulating oxidant/antioxidant system and mitochondria membrane potential, through mechanisms
related to ERs and GPER30 and kinases activation.
© 2018 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.
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Estrogens have been widely shown to exert many important
beneficial effects in skin physiology [1] targeting, among others,
keratinocytes and fibroblasts [2]; their importance in the
maintenance of human skin homeostasis is highlighted by the
acceleration of skin aging that can be observed in postmenopausal
women [3]. Overall, estrogens not only improve collagen content* Corresponding author at: Lab. Physiology and Experimental Surgery, Dept. of
Translational Medicine, University of Eastern Piedmont, via Solaroli 17, 28100
Novara, Italy.
E-mail address: elena.grossini@med.uniupo.it (E. Grossini).
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0923-1811/ © 2018 Japanese Society for Investigative Dermatology. Published by Elsevand quality, but they also increase skin thickness and vasculariza-
tion [4] and enhance keratinocytes migrations, as demonstrated
also in the wound healing process [5,6]. The protective effects
elicited by estrogens in skin cells could be related to the
modulation of peroxidation, as shown in dermal fibroblasts taken
from patients suffering from Friedreich’s ataxia [7]. Also phytoes-
trogens (i.e. non-steroidal plant compounds with estrogen-like
biological activity) represent promising alternatives for skin ageing
treatment. Among the others, and in particular, the phytoestrogens
genistein could exert antiphotocarcinogenetic and antiphotoaging
properties by modulation of oxidant/antioxidant balance [8,9].
Hence, genistein was shown to protect human dermal fibroblasts
against UV-induced senescence by upregulating intracellular
superoxide dismutase (SOD) activity [10], suggesting a potentialier B.V. All rights reserved.
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against reactive oxygen species (ROS)-induced apoptosis in the
human keratinocyte, HaCaT cell line [12]. In addition, it reduces
free radicals both in normal and in hyperproliferative fibroblasts
and counteracts the inhibition of collagen biosynthesis and the
antiproliferative effects of peroxidative stimuli more effectively
than ascorbate [13,14].
The effects of both estrogens and genistein on peroxidation
could be of particular relevance for clinical perspectives, since
increased inflammation and oxidative stress play a crucial role in
skin photoaging. ROS are generated from both the ultraviolet (UV)
sun light and endogenous oxidative metabolism by mitochondria
[15–17]. In physiological conditions, antioxidant enzymes, such as
SOD or glutathione (GSH), keep normal levels of ROS homeostasis
and counteract cellular stress; however, when the oxidant/
antioxidant ratio is shifted in favor of peroxidation, increased
ROS and oxidative stress can damage DNA, proteins, and lipids
leading to premature aging [17].
Another molecule that can be involved in photoaging phenom-
ena is represented by nitric oxide (NO), that may constitute a target
for estrogens and phytoestrogens [18,19]. NO is synthesized from L-
arginine by three isoforms of NOS, which are the inducible and
calcium-independent NOS (iNOS), and the constitutive and
calcium-dependent neuronal NOS (nNOS) and the eNOS [20].
While the constitutive NOS may act as a regulator of short-term
and physiological phenomena and is involved in a small amount of
NO release, the inducible NOS could be involved in longer-lasting
cytotoxic and inflammatory immunological functions, by produc-
ing NO at higher extent [21,22]. NO has been reported to be
associated with common forms of inflammatory skin diseases, thus
representing a possible therapeutic target [23,24]. Moreover, it
was also found to be over-secreted in response to UV irradiation by
iNOS isoform [25]. Hence, the reduction of NO release by human
keratinocytes was reported to be a mechanism of protection
against UV-induced senescence by garlic [26]. Similar effects were
found in the mouse skin, where the use of polyphenols and
anthocyanin was able to counteract iNOS activation by UV
irradiation [27].
Finally, although not clearly examined to date, changes of
mitochondrial function could also play a role in the mechanisms of
action of estrogens and phytoestrogens as antioxidant and anti-
aging factors in skin [7,28]
Both estrogen receptors (ERs), ERα and ERβ, which belong to the
superfamily of nuclear hormone receptors, and guanine nucleo-
tide-binding protein-coupled receptor, GPER30, could be involved
in eliciting the protective effects of estrogens, even if explicit data
regarding the mechanisms through which estrogens and phytoes-
trogens would exert their protection in the skin are still lacking
[29,30]. In respect of genistein, it would exert its effects on skin
mainly through ERβ [31], whereas information about the involve-
ment of GPER30 has not yet been reported.
Thus, in this study, we aimed to examine the protective effects
elicited by 17-β-estradiol and genistein against peroxidation in
human keratinocytes and fibroblasts and to analyze the involve-
ment of ERs, GPER30, NO, ROS and mitochondria.
2. Materials and methods
2.1. Isolation of human keratinocytes and fibroblasts from skin biopsy
and cell culture
Primary human keratinocytes were obtained from healthy skin
specimens surrounding benign cutaneous lesions excised at the
Dermatologic Unit of the Department of Health of Sciences,
University Eastern Piedmont “A. Avogadro”. To avoid variations due
to the age of the donor or prior photo exposure, skin from subjectsunder the age of 50 and from non-photo-damaged areas was used
only. Informed consent was previously obtained from all donors.
The study was approved by the local ethical committee. For at least
three times, the skin was immersed alternatively in 70% ethanol
and subsequently in saline solution to reduce contamination. Then
0.5–1 cm2 skins were incubated at 4 C overnight in 5 mg/ml
Dispase II (Sigma, Milan, Italy), 100 u/ml penicillin (Sigma) and
100 mg/ml streptomycin (Sigma). The following day, separation of
dermis/epidermis was performed. The epidermis was immersed in
2.5 ml 0.25% trypsin/0.02% EDTA (Euroclone, Pero, Milan, Italy) and
incubated at 37 C for 15–20 min. Then, 5 ml Dulbecco’s Modified
Eagle Medium (DMEM, Sigma) with 10% Foetal Bovine Serum (FBS,
Sigma) was added; the solution was pipetted vigorously up and
down 20–30 times and passed through a 100 mm Nylon filter
(Corning, Fisher Scientific Italia, Rodano, Italy). Extracted cells
were centrifuged at 970 rpm for 10 min. The cell pellet was
suspended in a 1 ml Epilife medium (Life Technologies Italia,
Monza, Italy), added with 1% Human Keratinocytes Growth
Supplement (HKGS, Life Technologies), 100 u/ml penicillin (Sigma)
and 100 mg/ml streptomycin (Sigma), 1% Gentamycin (Sigma) and
1% Amphotericin B (Sigma). Keratinocytes were transferred to a
Collagen IV-coated dish (100 mg/ml, Collagen from human
placenta; Sigma) containing 5 ml complete Epilife medium and
incubated at 37 C, 5% CO2 and 95% humidity. The medium was
changed after 24 h [32]. Following the same previously described
protocol, the dermis was immersed in 3 mg/ml Dispase II, 100 u/ml
penicillin (Sigma) and 100 mg/ml streptomycin (Sigma) and left for
4–5 h at 37 C, 5% CO2 and 95% humidity. Then, 6 ml DMEM with
10% FBS (Sigma) was added; the solution was pipetted vigorously
and passed through a 100 mm Nylon filter (Corning). Extracted
cells were centrifuged at 970 rpm for 10 min. The cell pellet was
suspended in a 1 ml of DMEM with 20% FBS (Euroclone), 2 mM L-
glutamine (Sigma) and 100 u/ml penicillin and 100 mg/ml strepto-
mycin (Sigma). Fibroblasts were transferred into a Collagen IV-
coated dish (Euroclone) containing 5 ml complete DMEM (Sigma)
and incubated at 37 C, 5% CO2 and 95% humidity. The medium was
changed after 24 h. For glutathione (GSH) quantification and
Western Blot, 34 105 cells were plated in 6 wells (Euroclone) in
a complete culture medium, and at the confluence, they were
incubated with starvation medium (DMEM without FBS) over-
night. For ROS quantification, 25 103 cells/well were plated in 96-
well (Euroclone) in a complete culture medium. For proliferation
rate, 5 103 cells/well were plated in xCELLigence 16-well plates
(Prodotti Gianni, Milan, Italy). Each experimental protocol was
repeated in five different cell samples.
2.2. NO production
The NO production was measured in keratinocytes and
fibroblasts culture supernatants using the Griess method (Prom-
ega, Milan, Italy), as previously performed in the same or similar
cellular models [33–36]. Fibroblasts and keratinocytes plated in
96-well plates in starvation medium were treated for 30 min with
genistein (10 nM- 1 mM- 100 mM; Sigma) and 17 β estradiol
(100 pM-10 nM-100 nM; Sigma). In different cell samples, the
effects of 30 min hydrogen peroxide (200 mM; Sigma) on NO
release alone or in presence of genistein and 17 β estradiol given
30 min before hydrogen peroxide, were also examined. The dose of
hydrogen peroxide was similar to the one used in similar studies
performed in both fibroblasts and keratinocytes [37–39]. In
addition, in some experiments, 30 min genistein (100 mM; Sigma)
and 17 β estradiol (100 nM; Sigma) were given after the pre-
stimulation with the ERs inhibitor, fulvestrant (equimolar; 15 min;
Sigma), the GPER30 antagonist, G15 (equimolar; 15 min; Santa
Cruz Biotechnologies, Inc., CA, USA), the NOS inhibitor, L-NAME
(equimolar; 15 min; Sigma), the phosphatidyl inositol 3 kinase
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mitogen-activated protein (MAP) kinase inhibitor, SB203580
(equimolar; 15 min; Sigma), and the extracellular signal–regulated
kinases (ERK) 1/2 inhibitor, UO126 (equimolar; 15 min; Sigma).
Acetylcholine was used for positive control (10 mM; 15 min;
Sigma). At the end of the stimulations, NO production in the
sample’s supernatants was examined by adding an equal volume of
Griess reagent following the manufacturer’s instruction. At the end
of incubation, the absorbance at 570 nm was measured by a
spectrometer (BS1000 Spectra Count, San Jose, CA, USA) and the
NO production was quantified in respect to nitrite standard curve
and expressed as a percentage. The values obtained correspond to
the NO (mmol) produced, after each stimulation, by samples
containing 1.5 mg of proteins each.
2.3. Cell viability
As described for NO release, dose-response experiments were
performed to examine the effects of genistein and 17 β-estradiol on
cell viability of fibroblasts and keratinocytes cultured in the
starvation medium. Control cells were treated with DMEM without
FBS and phenol red only. Cell viability was examined by using the
1% 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bro-
mide (MTT; Life Technologies Italia, Monza, Italy) dye, as
previously described [26–28]. Keratinocytes and fibroblasts were
also treated with hydrogen peroxide (200 mM; Sigma) alone or in
the presence of genistein (100 mM; Sigma) and 17 β estradiol
(100 nM; Sigma) given alone or 30 min before hydrogen peroxide.
In some experiments, genistein and 17 β-estradiol were given in
keratinocytes and fibroblasts pretreated with the same inhibitors
used for NO measurement. After each treatment, the medium was
removed, and fresh culture medium without red phenol and FBS
and with MTT dye was added in 96-well plates containing the cells
and incubated for 2 h at 37 C in an incubator. Thereafter, the
medium was removed, and an MTT solubilization solution in equal
volume to the original culture medium was added and mixed in a
gyratory shaker until the complete dissolution of formazan
crystals. Cell viability was determined by measuring the absor-
bance at 620 nm through a spectrometer (BS1000 Spectra Count,
San Jose, CA, USA), and cell viability was calculated by comparing
results with the control.
2.4. XCELLigence
For examining the proliferation rate, the xCELLigenceTM MP
Instrument (Roche, Basel, Switzerland) was used. Fibroblasts
and keratinocytes were harvested using trypsin-EDTA and
counted under light microscope. xCELLigence 16-well plates
(Prodotti Gianni) were prepared by the addition of complete
media to every well. After equilibration to 37 C, plates were
inserted into the xCELLigence station and the baseline imped-
ance was measured to ensure that all wells and connections
were working within acceptable limits. The software automati-
cally informs the researchers if any connection problem arises.
Following harvesting and counting, cells were diluted to the
correct seeding density and added to the wells in 100 ml. In
different cell samples, keratinocytes and fibroblasts were
treated with H2O2 for 30 min (200 mM; Sigma) alone or in the
presence of genistein (100 mM and 10 nM; Sigma) and 17β-
estradiol (100 nM and 100 pM; Sigma). The experiment was
stopped after 70 h and results analyzed after 12 h, 24 h, 48 h and
70 h. Cell-sensor impedance was expressed as an arbitrary unit
called the Cell Index. The Cell Index at each time point is defined
as (Rn-Rb)/15, where Rn is the cell-electrode impedance of the
well when it contains cells and Rb is the background impedance
of the well with the media alone.2.5. Mitochondrial membrane potential measurement
Mitochondrial membrane potential measurement in fibroblasts
and keratinocytes was performed with 5,51,6,61-tetrachloro-
1,11,3,31 tetraethyl-benzimiazolyl carbocyanine iodide assay.
Fibroblasts and keratinocytes were stimulated as for cell viability
examination. After stimulations, the medium of cells was removed
and incubated with 5,51,6,61-tetrachloro-1,11,3,31 tetraethyl-
benzimidazolyl carbocyanine iodide 1X diluted in Assay Buffer
1 for 15 min at 37 C in an incubator following the manufacturer’s
instruction (Invitrogen, Life Technologies Europe BV, Monza, Italy)
[34,36]. The dyes were dissolved in dimethylsulfoxide (Sigma), and
the percentage of the organic solvent in the samples never
exceeded 1% vol/vol. After incubation, the cells were washed twice
with Assay Buffer 1 and then the suspensions were transferred in
triplicates to a black 96-well plate. The red (excitation 550 nm/
emission 600 nm) and green (excitation 485 nm/emission 535 nm)
fluorescence were measured using a fluorescence plate reader
(BS1000 Spectra Count). To establish the cells undergoing
apoptosis, the ratio of red to green fluorescence was determined
and expressed as a percentage.
2.6. ROS quantification
The oxidation of 2,7-dichlorodihydrofluorescein diacetate into
2,7- dichlorodihydrofluorescein was used to assess ROS generation,
following the manufacturer’s instructions (Abcam, Cambridge,
United Kingdom), and as previously performed [34,35]. Briefly,
fibroblasts and keratinocytes in 96-well plates were stimulated
with hydrogen peroxide (200 mM, 30 min) in the absence or
presence of genistein (10 nM, 1 mM, 100 mM; Sigma) and 17 β-
estradiol (100 pM, 10 nM, 100 nM; Sigma). After treatments, the
reactions were stopped by removing the medium and washing
with phosphate buffer saline followed by staining with 10 mM 2,7-
dichlorodihydrofluorescein diacetate for 20 min at 37 C. The
fluorescence intensity of 2,7-dichlorodihydrofluorescein diacetate
was measured at excitation/emission wavelengths of 485 nm and
530 nm by using a spectrometer (BS1000 Spectra Count).
2.7. Glutathione (GSH) quantification
In keratinocytes and fibroblasts treated as described for
ROS quantification, the content of GSH was determined by
using a commercial kit according to the manufacturer’s
instructions (Cayman, Ann Arbor, Michigan, USA) [34–36].
Briefly, fibroblasts and keratinocytes were lysed on ice with
2 ml ice-cold Glutathione Assay Buffer and a rubber police-
man. Thereafter, cells were collected by centrifugation (2000g
for 10 min at 4 C). After centrifugation, the cell pellet was
homogenized in 2 ml cold Glutathione Assay Buffer [50 mM 2-
(N-morpholino) ethanesulfonic acid, containing 1 mM ethylene
diamine tetra-acetic acid] and vortexed for several seconds to
achieve a uniform emulsion. After samples were centrifuged at
10,000g for 15 min, at 4 C, the supernatants were removed and
stored on ice. The supernatants were deproteinized before
assaying to remove as much protein as possible from the
samples and avoid any interferences due to particulates and
sulfhydryl groups on proteins, as described in Glutathione assay
kit booklet. Briefly, an equal volume of metaphosphoric acid
(Sigma) was added to the samples which were vortexed. After
centrifugation at 2000g for 2 min, the supernatants were
collected and mixed with 4 M solution of triethanolamine
(TEAM; Sigma; 50 ml TEAM per ml of the supernatants). Then,
50 mL of the samples were transferred to a 96-well plate where
GSH was detected following the manufacturer’s instructions
through a spectrometer (BS1000 Spectra Count) at an excitation
Fig.1. Dose-response effects of genistein and 17 β-estradiol on NO release in human
fibroblasts (A) and keratinocytes (B). The values obtained correspond to the NO
(mmol) produced after each stimulation, by samples containing 1.5 mg of proteins
each. Reported data are means  SD of five independent experiments. C: control; G:
genistein; E: 17 β-estradiol. Square brackets indicate significance between groups.
*P < 0.05. *P < 0.05 vs C. **P < 0.05 vs H2O2.
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expressed as nmol/105 cells.
2.8. Cell lysates
When keratinocytes and fibroblasts reached confluence, the
complete medium was replaced with starvation medium (DMEM
without FBS) and incubated overnight at 37 C with 5% CO2.
For Western Blot analysis of p38MAPK, Akt and NOS, fibroblasts
and keratinocytes were stimulated with 30 min hydrogen peroxide
(200 mM) in the absence or presence of 30 min genistein (10 nM,
100 mM; Sigma) and 30 min 17 β-estradiol (100 pM, 100 nM;
Sigma). For Western Blot analysis of metalloproteases 1 (MMP-1)
and 9 (MMP-9), fibroblasts and keratinocytes were stimulated with
30 min hydrogen peroxide (200 mM) in the absence or presence of
24 h genistein (10 nM, 100 mM; Sigma) and 24 h 17 β-estradiol
(100 pM, 100 nM; Sigma). After the end of stimulations, keratino-
cytes and fibroblasts were lysed in iced-Ripa-buffer supplemented
with 1:200 sodium orthovanadate and 1:100 protease inhibitors
cocktail and phenylmethanesulfonyl fluoride (PMSF; 1:100;
Sigma). The extract proteins were quantified through bicincho-
ninic acid protein (BCA; Pierce, Rockford, IL, USA) and used for
electrophoresis and immunoblotting studies [34–36].
2.9. Western blotting
Cell lysates (30 mg protein each sample) dissolved in Laemmli
buffer 5 and boiled for 5 min, were resolved in 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
gels (Bio-Rad Laboratories, Hercules, CA, USA) and after electro-
phoresis, were transferred to polyvinylidene fluoride (PVDF)
membranes (Bio-Rad Laboratories), which were incubated over-
night at 4 C with specific primary antibodies: anti phospho-Akt
(p-Akt, 1:1000; Ser473, Santa Cruz Biotechnology, Dallas, USA),
anti Akt (1:1000; Santa Cruz Biotechnology), anti phospho-p38
MAPK (pp-38 MAPK, 1:1000; Thr180/Thr182, Cell Signalling
Technologies, Danvers, USA), anti p38 MAPK (1:1000; Cell
Signalling Technologies), anti phospho-endothelial NOS (eNOS;
1:1000; Ser1177, Cell Signalling Technologies), anti-endothelial
NOS (eNOS: 1:500; Santa Cruz Biotechnology), iNOS (1:500; Santa
Cruz Biotechnology), anti MMP-1 (2 mg/ml; R&D Systems, Min-
neapolis, USA) and anti MMP-9 (0.1 mg/ml; R&D Systems). The
membranes were washed and then incubated with horseradish
peroxidase-coupled goat anti-rabbit IgG (Sigma), peroxidase-
coupled rabbit anti-goat IgG and horseradish peroxidase-coupled
goat anti-mouse IgG (Sigma) for 45 min and were developed
through a nonradioactive method using Western Lightning
Chemiluminescence (PerkinElmer Life and Analytical Sciences,
Waltham, MA, USA). Phosphorylated protein expression was
calculated as a ratio towards specific total protein expression or
β-actin (1:5000; Sigma) detection.
2.10. Statistical analysis
All data were recorded using the Institution's database.
Statistical analysis was performed by using STATVIEW version
5.0.1 for Microsoft Windows (SAS Institute Inc., Cary NC, USA). Data
were checked for normality before statistical analysis. All the
results obtained were examined through one-way ANOVA
followed by Bonferroni post hoc tests. The non-parametric Mann
Whitney U test for unpaired data was used to compare percentage
responses. Pearson coefficient was calculated for linear correlation
analysis in dose-response studies. All data are presented as
means  SD of five independent experiments for each experimen-
tal protocol. A value of p < 0.05 was considered statistically
significant.3. Results
3.1. Effects of genistein and 17 β-estradiol on NO release
In fibroblasts and keratinocytes cultured in physiological
conditions, genistein, 10 nM, 1 mM and 100 mM, increased NO
release to 1.8%, 2.9%, 4.5% and 2.2%, 3.5% and 4.4% from
respective control values (Fig. 1A and B). In the same cells,
the NO release caused by 17 β-estradiol, 100 pM, 10 nM and
100 nM, amounted to 2.8%, 3.8%, 6.1% and 3.7%, 4.6%, 4.9% from
respective control values (Fig. 1). In cells pretreated with
hydrogen peroxide, NO release was increased to about 55% and
61% of control values, an effect which was counteracted by both
agents (Fig. 1). Moreover, genistein and 17 β-estradiol were able
to dose-dependently reduce the eNOS and iNOS activation/
expression caused by the peroxidative stimuli (Fig. 2). The dose
of hydrogen peroxide chosen, amounting to 200 mM, was similar
to the one previously used for studies about skin aging induced
by irradiation [37] and about protective effects elicited by
isoflavones or peptides in both fibroblasts and keratinocytes
[38–40].
In addition, on the ground of the above results, we decided
to use 17 β-estradiol and genistein for all next experiments at
Fig. 2. Effects of genistein and 17 β-estradiol on activation/expression of eNOS and iNOS in human fibroblasts (A, C) and keratinocytes (B, D) cultured in peroxidative
conditions. In A–D, densitometric analysis and an example of Western Blot taken from 5 different experiments of p-eNOS and iNOS are shown. In each sample, densitometric
analysis was performed by taking the percentage change of phosphorylated eNOS vs eNOS or iNOS vs β actin. Abbreviations are as in Fig. 1. Reported data are means  SD of
five independent experiments. Square brackets indicate significance between groups. *P < 0.05. **P < 0.05 vs control. #P < 0.05 vs H2O2.
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were used in previous studies aimed to examine the protective
effects elicited by 17 β-estradiol and genistein in fibroblasts
and keratinocytes against aging or UV-mediated damages
[6,13,41].3.2. Role of ERs, GPER30, NOS, PI3K, ERK1/2 and p38MAPK in the
effects of genistein and 17 β-estradiol on NO release
The effects of genistein and 17 β-estradiol in fibroblasts
(Fig. 3A and B) and keratinocytes (Fig. 3C and D) cultured in
Fig. 3. Effects of genistein and 17 β-estradiol on NO release in human fibroblasts (A, B) and keratinocytes (C, D) in the presence or absence of various inhibitors. The values
obtained correspond to the NO (mmol) produced after each stimulation, by samples containing 1.5 mg of proteins each. F: fulvestrant, ERs inhibitor; G15: GPER30 inhibitor; L-
NAME = Nv-nitro-L-arginine methylester, NOS inhibitor; W: wortmannin, the phosphatidyl inositol 3 kinase inhibitor; UO: UO126, the extracellular signal–regulated kinases
inhibitor; SB: SB203580, the p38 mitogen activated protein kinases inhibitor. Other abbreviations are as in previous Figures. Reported data are means  SD of five independent
experiments. Square brackets indicate significance between groups. *P < 0.05. *P < 0.05 vs C. **P < 0.05 vs H2O2.
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inhibitor, fulvestrant, the GPER30 blocker, G15, the NOS inhibitor,
L-NAME, the PI3K blocker, wortmannin, the ERK1/2 blocker,
UO126, and the p38MAPK blocker, SB203580. In contrast, in
fibroblasts in peroxidative condition the protective effects of
genistein and 17 β-estradiol were reduced by fulvestrant and G15
(Fig. 3A), as NO release was higher than NO release under
genistein and 17 β-estradiol given without the blockers.
Nevertheless, wortmannin improved the effects of both estradiol
and genistein as the NO releases decreased (Fig. 3B). L-NAMEimproved as well both protective effects (Fig. 3A). UO126
improved the protective effects of genistein as NO release
decreased, but it contributed to the NO release in the presence
of estradiol. SB203580 counteracted the protective effects of
genistein and 17 β-estradiol as in both cases NO release increased
(Fig. 3B). In keratinocytes treated with hydrogen peroxide all the
above inhibitors except L-NAME hindered the response of cells to
both the phytoestrogens and estrogens. Hence, the release of NO
caused by hydrogen peroxide was reduced less by genistein and
17 β-estradiol (Fig. 3C and D).
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mitochondrial membrane potential
Regarding cell viability, genistein and 17 β-estradiol elicited
opposite effects in fibroblasts and keratinocytes cultured in
physiological conditions. In fibroblasts, we observed a dose-
related increase of cell viability after treatment with estrogens
(Fig. 4A) and a reduction after treatment with phytoestrogensFig. 4. Dose-response effects of 17 β-estradiol and genistein on cell viability of human fibr
data are means  SD of five independent experiments. R: Pearson’s relation coefficient(Fig. 4B). Opposite results were obtained in keratinocytes (Fig. 4C
and D). In any case, the mitochondrial membrane potential was
improved by both agents (Fig. 5). In peroxidative conditions, 17 β-
estradiol enhanced the mitochondrial membrane potential in a
dose-dependent manner in both cell types (Fig. 5), while genistein
in fibroblasts decreased mitochondrial membrane potential with
increasing doses (Fig. 5A) and increased it in a dose-dependent
way in keratinocytes (Fig. 5B). Moreover, in keratinocytes andoblasts (A, B) and keratinocytes (C, D) cultured in physiological conditions. Reported
. Abbreviations are as in previous Figures.
Fig. 5. Dose-response effects of genistein and 17 β-estradiol on mitochondrial
membrane potential of human fibroblasts (A) and keratinocytes (B) cultured in
physiological and peroxidative conditions. Reported data are means  SD of five
independent experiments. Abbreviations are as in previous Figures. Reported data
are means  SD of five independent experiments. Square brackets indicate
significance between groups. *P < 0.05. *P < 0.05 vs C. **P < 0.05 vs H2O2.
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17 β-estradiol prevented the fall of cell viability and of
mitochondrial membrane potential (Figs. 5–7).
3.4. Role of ERs, GPER30, NOS, PI3K, ERK1/2 and p38MAPK in the
effects of genistein and 17 β-estradiol on cell viability and
mitochondrial membrane potential
In addition, and as shown in Figs. 6 and 7, A and C, in
keratinocytes and fibroblasts treated with fulvestrant and G15, the
effects of those agents on cell viability and mitochondrial
membrane potential were reduced, both in physiological and
peroxidative conditions. Hence, in the presence of those blockers,
the effects of genistein and estradiol were lower than those found
in the absence of blockers. Similar responses were observed in cells
pretreated with L-NAME, wortmannin, UO126, and SB203580
(Figs. 6 and 7).
3.5. Role of PI3K and p38MAPK in the effects of genistein and 17 β-
estradiol against peroxidation
As shown in Fig. 8, also Western Blot analysis confirmed the
involvement of PI3K-Akt (A and B) and p38MAPK (C and D) in the
effects of both genistein and 17 β-estradiol against the peroxidative
damage in fibroblasts (A, C) and keratinocytes (B, D). In particular,
and regarding Akt, both genistein and 17 β-estradiol were able to
hinder the reduction of its activation caused by hydrogen peroxide(Fig. 8A and B); regarding p38MAPK, both agents enhanced the
effects of the oxidative stimuli (Fig. 8C and D).
3.6. Antioxidant effects elicited by genistein and 17 β-estradiol
Of more relevance is that the protective effects elicited by
genistein and 17 β-estradiol were accompanied by a dose-related
reduction of ROS release (Fig. 9A and B) and by an increase of GSH
content in both cell types (Fig. 9C and D). Since GSH content is one
of the main mechanisms, among others, to cope with ROS, it could
be argued that the protective effects elicited by both genistein and
estradiol were related to the dose-dependent modulation of the
oxidant/antioxidant system in fibroblasts and keratinocytes.
3.7. Modulation of proliferation and MMPs expression by genistein
and 17 β-estradiol
In addition, genistein and 17 β-estradiol increased proliferation
of cells cultured in physiological medium (Fig. 10A and B) and
prevented the effects of hydrogen peroxide (Fig. 10C and D). Those
effects were similar to those concerning cell viability and also in
relation to the doses administrated (Fig. 6). Hence, in fibroblasts,
we observed a dose-related increase of cell proliferation after
treatment with 17 β-estradiol and a reduction in the presence of
genistein (Fig. 10A). The opposite results were found in keratino-
cytes (Fig. 10C). Finally, both the estrogen and phytoestrogen were
able to dose-dependently counteract the effects of hydrogen
peroxide on MMP-1 and MMP-9 expression (Fig. 11). Since, MMPs
play an important role in photoaging, our results showing
inhibitory effects on MMPs activation caused by peroxidation
would highlight a role for estrogens and phytoestrogens as
potential antiaging tools.
4. Discussion
In this study we demonstrate a protective effect against
peroxidative injuries of genistein and 17 β-estradiol on fibroblasts
and keratinocytes, by modulating NO and ROS release, GSH content
and mitochondria function. The involvement of ERs, GPER30 and of
signaling related to PI3K-Akt, p38 MAPK, and ERK1/2 has also been
highlighted.
Oxidative stress induced by ROS is widely accepted as the major
driving force of the aging process. Hence, the age-related increase
in ROS generation and oxidative injuries have been reported in a
variety of tissues including the skin [42]. Human skin is exposed to
ROS generated from both environmental sources as well as the
endogenous oxidative metabolism [43] and, for this reason,
photoaging (i.e. extrinsic aging mainly caused by UV) accelerates
the physiological aging process of the skin (i.e. intrinsic aging)
[44,45].
Physiological skin aging is a process which can be modulated by
multiple factors, including hormonal fluctuations. Many studies
demonstrated that estrogens can exert significant beneficial and
protective roles in the skin: variations in skin thickness are
observed during the menstrual cycle [3], whereas in the
postmenopausal age estrogens deficiency accelerates structural
and functional changes (i.e. fragmentation of elastin fibers, damage
of dermal vessels and reduction of collagen production) [46]. Many
of these effects can be reversed by estrogen replacement, which
increases epidermal hydration, elasticity, and thickness, and
enhances the content and quality of collagen [13]. Consequently,
estrogens can also offer some protection against skin photoaging
[47,48].
Genistein, the main isoflavone contained in soybeans and in
certain fermented soy foods, has been shown to be a promising
anti-aging and anti-carcinogenic agent for skin care, due to its
Fig. 6. Effects of genistein and 17 β-estradiol on cell viability in human fibroblasts (A, B) and keratinocytes (C, D) in the presence or absence of various inhibitors. Abbreviations
are as in previous Figures. Reported data are means  SD of five independent experiments. Square brackets indicate significance between groups. * P < 0.05. *P < 0.05 vs C.
**P < 0.05 vs H2O2.
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use in the prevention and treatment of skin aging after menopause
[41,49,50].
In our study, 17 β-estradiol was able to cause a dose-related or
dose-inverse positive effect on cell viability and proliferation of
human keratinocytes (Figs. 4C and 10 C, D) and fibroblasts (Figs. 4A
and 10 A, B). It is to note that these results were obtained with
concentrations of 17 β-estradiol, amounting to 109–107M, that
were similar to those found in menstrual/menopausal women
[50,51] and analogous to those used in similar studies performed in
skin fibroblasts and keratinocytes [6,13,41]. The opposite response
was observed with genistein, administrated at nutritional concen-
tration, like those previously used in keratinocytes (Figs. 4D and 10
C, D) and fibroblasts (Figs. 4B and 10 A, B) [13]. Notably, both agents
were able to improve mitochondrial membrane potential and to
increase NO release in physiological conditions and to hinder the
fall of mitochondrial membrane potential and the increased NO
release caused by hydrogen peroxide.
In this study, we demonstrate that both 17 β-estradiol and
genistein reduced ROS release, while increasing GSH level, which
was accompanied by the keeping of cell viability and animprovement of the proliferation rate. Since, the up-to-date
information about the effects of 17 β-estradiol and genistein on
ROS and NO release is scarce, our findings do increase the
knowledge about this issue. Moreover, we confirm the cytopro-
tective effects of estrogens and genistein previously described by
other authors [3]; although their precise mechanism of action is
unclear, a role could be played by their anti-inflammatory and
antioxidant action.
As mentioned above, our results regarding the modulation of
NO release and mitochondria membrane potential could suggest a
possible novel mechanism through which estrogens/phytoestro-
gens would exert their protective effects against peroxidation. The
fact that NO could exert protection or damage would thus depend
on its concentration and on the relative activity of the constitutive
or inducible NOS [21]. Moreover, it is to note that eNOS itself could
be strongly activated in the presence of peroxidation and change its
function. In respect of this issue, it is worth noting that eNOS has
been reported to be a redox “hub”, being regulated by and
contributing to the regulation of intracellular redox homeostasis
through mutually interacting tetrahydrobiopterin- and GSH-
dependent pathways. Changes of GSH have been reported to
Fig. 7. Effects of genistein and 17 β-estradiol on mitochondrial membrane potential in human fibroblasts (A, B) and keratinocytes (C, D) in the presence or absence of various
inhibitors. Abbreviations are as in previous Figures. Reported data are means  SD of five independent experiments. Square brackets indicate significance between groups. *
P < 0.05. *P < 0.05 vs C. **P < 0.05 vs H2O2.
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from NO to superoxide production. This could, in turn, increase
iNOS activation and strengthen NO release [21].
Thus, the opposite effects of genistein and 17 β-estradiol on NO
release in physiological/peroxidative conditions could be related to
changes in NOS subtypes recruitment and in eNOS function. While
in physiological conditions those agents would act mainly through
eNOS subtype, which would cause just minor changes in NO
release, in the presence of hydrogen peroxide they would reduce
NO release by inhibiting both eNOS and iNOS.
Some speculations could be made about the pathways at the
basis of those effects. Hence in our study p-Akt and p38MAPK,
which are widely considered as eNOS activators [52], were found to
be inhibited and activated, respectively by both estrogens and
genistein in fibroblasts and keratinocytes that have undergone
peroxidation. Although this point has not been fully examined, we
could hypothesize that the reduction of ROS release is involved inthe reduction of NOS isoforms activation/expression by the
modulation of the crosstalk between Akt/p38MAPK, and/or of
pathways related to nicotinamide adenine dinucleotide phosphate
oxidase, extracellular signal–regulated kinases 1/2, phospholipase
C, 50 adenosine monophosphate-activated protein kinase and Ca2
+/calmodulin-dependent protein kinase II [53–55]. Also, Nf-kb
could be involved in the effects of genistein on NOS isoforms. As
shown by Duarte et al. [56], flavonoids were found to prevent the
inflammatory signaling cascades through downregulation of iNOS
associated to NF-kb inhibition. Thus, all the above intracellular
signaling cascades could be object of further investigations.
Another key pointof our study is represented by the confirmation
of the role of mitochondria in aging; this has been highlighted in
recent years [57]. Mitochondria could be both sources and targets of
damage by free radicals. Furthermore, the fall of mitochondrial
membrane potential could act as an initiating event leading to the
activation of apoptotic cell death by the release of cytochrome C.
Fig. 8. Effects of genistein and 17 β-estradiol on Akt and p38MAPK activation in human fibroblasts (A, C) and keratinocytes (B, D) cultured in peroxidative conditions. In A–D,
densitometric analysis and an example of Western Blot taken from 5 different experiments of p-Akt and p-p38MAPK are shown. p-Akt: phosphorylated Akt; p-p38MAPK:
phosphorylated p38MAPK. In each sample, densitometric analysis was performed by taking the percentage change of phosphorylated Akt or p38MAPK vs Akt and p38MAPK.
Other abbreviations are as in previous Figures. Reported data are means  SD of five independent experiments. Square brackets indicate significance between groups. *
P < 0.05. **P < 0.05 vs control. #P < 0.05 vs H2O2.
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from studies on gender-related longevity. Oxidant production by
mitochondria is much higher in males than in females [58]; thisphenomenon has been found to be related to the action of estrogens [
59]. Regarding this issue, estradiol has been reported to prevent the
release of cytochrome C from mitochondria and also to increase the
Fig. 9. Effects of genistein and 17 β-estradiol on ROS release and GSH content in human fibroblasts (A, C) and keratinocytes (B, D) cultured in peroxidative conditions.
Abbreviations and layout are as in previous Figures. Reported data are means  SD of five independent experiments. Square brackets indicate significance between groups.
*P < 0.05. *P < 0.05 vs C. **P < 0.05 vs H2O2.
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respiratory chain. Similar findings have also been described
regarding genistein [28]. Thus, our results about mitochondria
function would confirm previous observations.
The effects of 17 β-estradiol and genistein on mitochondrial
membrane potential could partly explain the discrepancies
observed regarding cell viability and cell proliferation. It could
be assumed that only strong increases of mitochondrial membrane
potential would be needed to obtain beneficial effects on both
parameters, with particular reference to cell viability. Hence, in the
presence of dose-related increases of mitochondrial membrane
potential, in both fibroblasts and keratinocytes a dose-related
increase of cell viability was found. Furthermore, epidermal
homeostasis is regulated by a balance between proliferation and
differentiation. In this context, Notch signaling could play a role in
the control of cellular proliferation, differentiation and survival in
both physiological and pathological, and would be object of further
analysis [60].
Moreover, in our experience almost all effects of genistein and
17 β-estradiol on cell viability and mitochondrial membrane
potential were abolished or reduced by fulvestrant, G15, wort-
mannin, SB203580, and UO126. Those findings highlight the
involvement of both ERs and GPER30 receptors and of PI3K-Akt, thep38MAPK and the ERK1/2- related signaling in the mechanisms of
action of those agents. Western Blot analysis confirmed the
engagement of Akt and p38MAPK.
Previous studies have shown that in keratinocytes and dermal
fibroblasts protection against oxidative injuries by estrogens and
genistein is mediated by ERβ rather ERα. It is also notable that
ERβ has been found to be more expressed in skin cells [61].
Also, the seven-transmembrane receptor, GPER30, has been
reported to be involved in the effects of estrogens in human skin
cells [62].
The presence of the above membrane estrogen receptors
coupled to cytosolic signal transduction proteins could activate
direct signaling cascades via conventional second messengers
including MAPK producing rapid responses to estrogen [3]. In this
context, it is notable that the antioxidant action of estrogens is due
to their interaction with estrogen receptors in cells which
eventually could lead to the activation of MAPK [28]. However,
in a model of ischemia/reperfusion injury, estradiol was found to
counteract the activation of p38MAPK [58]. Similarly, genistein
could reduce the UVB-activation of MAPK cascade in Wistar rats [
59].
Therefore, our findings showing potentiating effects of both
estradiol and genistein on p38MAPK would disagree with those
Fig. 10. Effects of genistein and 17 β-estradiol on proliferation of human fibroblasts (A, B) and keratinocytes (C, D) cultured in physiological (A, C) and peroxidative conditions
(B, D). Reported data are means  SD of five independent experiments.
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range of extracellular stimuli, such as inflammation and UV
radiation and can influence various cellular processes, including
proliferation, differentiation, and apoptosis [63]. About this issue,
in human keratinocytes, both anti- and pro-apoptotic responses
were found following UV-induced activation of p38MAPK [64].
Moreover, curcuminoid treatment was able to inhibit keratinocyte
growth by p38 MAPK activation [64]. The cause of those disparate
and opposite effects of p38MAPK is not clear but interplay with
other signaling pathways, as well as the nature of p38 MAPK
substrates, could account for them.
Regarding the involvement of other intracellular kinases, both
ERK1/2 and PI3K-Akt have been reported to be crucial for
keratinocyte proliferation induced by the application of exogenous
estrogen [6,65]. By this way, our observations obtained withWestern Blot about Akt activation could be related to the protective
effects exerted by both estradiol and genistein on proliferation rate
in fibroblasts and keratinocytes.
The results obtained about MMP1 and 9 expression could be of
clinical relevance. Hence, collagen degradation is tightly related to
the presence of matrix MMPs, which are mainly secreted by
epidermal keratinocytes and dermal fibroblasts. The expression of
MMPs, which is quite low in unstimulated cells, can be induced by
various extracellular stimuli including UV and infrared radiation [
66]. Among various MMPs, MMP-1 is widely considered as the key
enzyme responsible for breaking down dermal components in the
extracellular matrix. Once the increased levels of MMP-1 has
started the degradation of collagen, further processing is followed
by MMP-3 and MMP-9. Therefore, MMP-1 plays a significant role in
the initiation of UVB-induced wrinkle formation and in photoaging
Fig. 11. Effects of genistein and 17 β-estradiol on MMP-1 and MMP-9 in human fibroblasts (A, C) and keratinocytes (B, D) cultured in peroxidative conditions. In A–D,
densitometric analysis and an example of Western Blot taken from 5 different experiments of MMP-1 and MMP-9 are shown. In each sample, densitometric analysis was
performed by taking the percentage change of MMP-1 and MMP-9 vs β actin. MMP: metalloprotease. Other abbreviations are as in previous Figures. Reported data are
means  SD of five independent experiments. Square brackets indicate significance between groups. *P < 0.05. **P < 0.05 vs control. #P < 0.05 vs H2O2.
P. Savoia et al. / Journal of Dermatological Science 92 (2018) 62–77 75through matrix degradation [67]. For the above reasons, our results
showing inhibitory effects elicited by estrogens and phytoestro-
gens on MMPs activation caused by peroxidation would highlight
their role as potential antiaging tools.
In conclusion, our study demonstrates that 17 β-estradiol and
genistein could counteract skin aging by modulating GSH content
and ROS release, eNOS/iNOS dependent- NO release, MMPs
expression and mitochondria membrane potential in both human
fibroblasts and keratinocytes. Through mechanisms involving
p38MAPK, Akt, and ERK1/2, as downstream signaling of ERs and
GPER30, those agents would keep cell viability and proliferation
rate, which would be altered by oxidative stress.Funding sources
None.
Conflict of interest
Theauthors have no conflict of interest to declare.
Author declaration
All authors made substantial contributions to conception and
design, acquisition of data, or analysis and interpretation of data.
76 P. Savoia et al. / Journal of Dermatological Science 92 (2018) 62–77All authors drafted the article or reviewed it critically for
important intellectual content.
All authors gave final approval of the version to be published.
Aknowledgements
We thank all skin donors and the “Azienda Ospedaliero-
Universitaria Maggiore della Carità” of Novara for its support in this
study. This research did not receive any specific grant from funding
agencies in the public, commercial, or not-for-profit sectors.
Appendix A. Supplementary data
Supplementary material related to this article can be found,
in the online version, at doi:https://doi.org/10.1016/j.jdermsci.
2018.07.007.
References
[1] M.J. Thornton, The biological actions of estrogens on skin, Exp. Dermatol. 11
(2002) 487–502.
[2] M.J. Thornton, Oestrogen functions in skin and skin appendages, Expert Opin.
Ther. Targets 9 (2005) 617–629.
[3] M.J. Thornton, Estrogens and aging skin, Dermatol. Endocrinol. 5 (2013) 264–
270.
[4] M.P. Brincat, Hormone replacement therapy and the skin, Maturitas 29 (2000)
107–117.
[5] J.U. Shin, J.Y. Noh, S. Jin, S.H. Kim, D.K. Rah, D.W. Lee, J.S. Yoo, K. Kim, Y.S. Lee, I.
Jung, J.H. Lee, K.H. Lee, Estrogen upregulates slug to enhance the migration of
keratinocytes, J. Invest. Dermatol. 135 (2015) 3200–3203.
[6] T. Zhou, Z. Yang, Y. Chen, Z. Huang, B. You, Y. Peng, J. Chen, Estrogen accelerates
cutaneous wound healing by promoting proliferation of epidermal
keratinocytes via Erk/Akt signaling pathway, Cell. Physiol. Biochem. 38 (2016)
959–968.
[7] T.E. Richardson, A.E. Yu, Y. Wen, S.H. Yang, J.W. Simpkins, Estrogen prevents
oxidative damage to the mitochondria in Friedreich’s ataxia skin fibroblasts,
PLoS One 7 (2012)e34600.
[8] G. Bottai, R. Mancina, M. Muratori, P. Di Gennaro, T. Lotti,17β-estradiol protects
human skin fibroblasts and keratinocytes against oxidative damage, J. Eur.
Acad. Dermatol. Venereol. 27 (2013) 1236–1243.
[9] H. Wei, R. Saladi, Y. Lu, S.R. Palep, J. Moore, R. Phelps, et al., Genistein, the most
widely studied isoflavone, is derived from soy bean–based products.
Isoflavone genistein: phytoprotection and clinical implications in
dermatology, J. Nutr. 133 (Suppl) (2003) 3811–3819.
[10] Y.N. Wang, W. Wu, H.C. Chen, H. Fang, Genistein protects against UVB-induced
senescence-like characteristics in human dermal fibroblast by p66Shc down-
regulation, J. Dermatol. Sci. 58 (2010) 19–27.
[11] L.A. Silva, A.A. Ferraz Carbonel, A.R.B. de Moraes, R.S. Simões, G.R.D.S. Sasso, L.
Goes, W. Nunes, M.J. Simões, M.T. Patriarca, Collagen concentration on the
facial skin of postmenopausal women after topical treatment with estradiol
and genistein: a randomized double-blind controlled trial, Gynecol.
Endocrinol. 16 (2017) 1–4.
[12] M. Fukunaga, M. Oka, M. Ichihashi, T. Yamamoto, H. Matsuzaki, U. Kikkawa,
UV-induced tyrosine phosphorylation of PKC delta and promotion of apoptosis
in the HaCaT cell line, Biochem. Biophys. Res. Commun. 289 (November (2))
(2001) 573–579.
[13] P. Sienkiewicz, A. Surazynski, J. Pałka, W. Miltyk, Nutritional concentration of
genistein protects human dermal fibroblasts from oxidative stress-induced
collagen biosynthesis inhibition through IGF-I receptor-mediated signaling,
Acta Pol. Pharm. 65 (2008) 203–211.
[14] M. Jurzak, P. Ramos, B. Pilawa, The influence of genistein on free radicals in
normal dermal fibroblasts and keloid fibroblasts examined by EPR
spectroscopy, Med. Chem. Res. 26 (2017) 1297–1305.
[15] T. Quan, G.J. Fisher, Role of age-associated alterations of the dermal
extracellular matrix microenvironment in human skin aging: a mini-
review, Gerontology 61 (2015) 427–434.
[16] M. Yaar, M.S. Eller, B.A. Gilchrest, Fifty years of skin aging, J. Invest. Dermatol.
Symp. Proc. 7 (2002) 51–58.
[17] H. Masaki, Role of antioxidants in the skin: anti-aging effects, J. Dermatol. Sci.
58 (2010) 85–90.
[18] G. Vacca, A. Battaglia, E. Grossini, D.A. Mary, C. Molinari, N. Surico, The effect of
17beta-oestradiol on regional blood flow in anaesthetized pigs, J. Physiol. 514
(1999) 875–884.
[19] E. Grossini, C. Molinari, D.A. Mary, F. Uberti, P.P. Caimmi, N. Surico, G. Vacca,
Intracoronary genistein acutely increases coronary blood flow in anesthetized
pigs through beta-adrenergic mediated nitric oxide release and estrogenic
receptors, Endocrinology 149 (2008) 2678–2687.
[20] W.K. Alderton, C.E. Cooper, R.G. Knowles, Nitric oxide synthases: structure,
function and inhibition, Biochem. J. 357 (2001) 593–615.[21] I.M. Goldstein, P. Ostwald, S. Roth, Nitric oxide: a review of its role in retinal
function and disease, Vis. Res. 36 (1996) 2979–2994.
[22] R. Korhonen, A. Lahti, H. Kankaanrant, E. Moilanen, Nitric oxide production and
signaling in inflammation, Curr. Drug Targets Inflamm. Allergy 4 (2005) 471–
479 5253, 54.
[23] J. Yang, S. Min, S. Hong, Therapeutic effects of fermented flax seed oil on NC/
Nga mice with atopic dermatitis-like skin lesions, Evid. Based Complement.
Altern. Med. (2017) 5469125, doi:http://dx.doi.org/10.1155/2017/5469125.
[24] J.H. Park, J.Y. Choi, D.J. Son, E.K. Park, M.J. Song, M. Hellström, J.T. Hong, Anti-
inflammatory effect of titrated extract of Centella asiatica in phthalic
anhydride-induced allergic dermatitis animal model, Int. J. Mol. Sci. 18 (2017),
doi:http://dx.doi.org/10.3390/ijms18040738 pii: E738.
[25] G. Deliconstantinos, V. Villioto, J.C. Stavrides, Nitric oxide and peroxynitrite
released by ultraviolet B-irradiated human endothelial cells are possibly
involved in skin erythema and inflammation, Exp. Physiol. 81 (1996) 1021–
1033.
[26] H.K. Kim, Protective Effect of Garlic on Cellular Senescence in UVB-Exposed
HaCaT Human Keratinocytes, Nutrients 8 (2016), doi:http://dx.doi.org/
10.3390/nu8080464.
[27] H. Kuo, T.Y. Lin, Y.J. You, K.C. Wen, P.J. Sung, H.M. Chiang, Antiinflammatory and
Antiphotodamaging Effects of Ergostatrien-3β-ol, Isolated from Antrodia
camphorata, on Hairless Mouse Skin, Molecules 21 (2016), doi:http://dx.doi.
org/10.3390/molecules21091213.23 pii: E1213.
[28] C. Borrás, J. Gambini, R. López-Grueso, F.V. Pallardó, J. Viña, Direct antioxidant
and protective effect of estradiol on isolated mitochondria, J. Biochem.
Biophys. Acta 1802 (2010) 205–211.
[29] S. Moverare, M.K. Lindberg, J. Faergemann, J.A. Gustafsson, C. Ohlsson,
Estrogen receptor alpha, but not estrogen receptor beta, is involved in the
regulation of the hair follicle cycling as well as the thickness of epidermis in
male mice, J. Invest. Dermatol. 119 (2002) 1053–1058.
[30] N. Kanda, S. Watanabe, 17beta-estradiol inhibits oxidative stress-induced
apoptosis in keratinocytes by promoting Bcl-2 expression, J. Invest. Dermatol.
121 (2003) 1500–1509.
[31] R.S. Muthyala, Y.H. Ju, S. Sheng, L.D. Williams, D.R. Doerge, B.S.
Katzenellenbogen, W.G. Helferich, J.A. Katzenellenbogen, Equol, a natural
estrogenic metabolite from soy isoflavones: convenient preparation and
resolution of R- and S-equols and their differing binding and biological activity
through estrogen receptors alpha and beta, Bioorg. Med. Chem. 12 (2004)
1559–1567.
[32] S. Zarei, M.A. Zarei, T. Ghadimi, F. Fathi, A. Jalili, M.S. Hakhamaneshi, Isolation,
cultivation and transfection of human keratinocytes, Cell Biol. Int. 38 (2014)
444–451.
[33] E. Grossini, S. Farruggio, F. Qoqaiche, G. Raina, L. Camillo, L. Sigaudo, D. Mary, N.
Surico, D. Surico, Monomeric adiponectin modulates nitric oxide release and
calcium movements in porcine aortic endothelial cells in normal/high glucose
conditions, Life Sci. 161 (2016) 1–9.
[34] D. Surico, S. Farruggio, P. Marotta, G. Raina, D. Mary, N. Surico, G. Vacca, E.
Grossini, Human chorionic gonadotropin protects vascular endothelial cells
from oxidative stress by apoptosis inhibition, cell survival signalling activation
and mitochondrial function protection, Cell. Physiol. Biochem. 36 (2015) 2108–
2120.
[35] E. Grossini, K. Bellofatto, S. Farruggio, L. Sigaudo, P. Marotta, G. Raina, V. De
Giuli, D. Mary, P. Pollesello, R. Minisini, M. Pirisi, G. Vacca, Levosimendan
inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy
interplay, PLoS One 10 (2015) e0124742 36.
[36] E. Grossini, C. Gramaglia, S. Farruggio, K. Bellofatto, C. Anchisi, D. Mary, G.
Vacca, P. Zeppegno, Asenapine increases nitric oxide release and protects
porcine coronary artery endothelial cells against peroxidation, Vasc.
Pharmacol. 60 (2014) 127–141.
[37] A. Ge˛gotek, K. Bielawska, M. Biernacki, I. Zare˛ba, A. Sura _zynski, E.
Skrzydlewska, Comparison of protective effect of ascorbic acid on redox
and endocannabinoid systems interactions in in vitro cultured human skin
fibroblasts exposed to UV radiation and hydrogen peroxide, Arch. Dermatol.
Res. 309 (2017) 285–303.
[38] A. Ortiz-Espín, E. Morel, A. Juarranz, A. Guerrero, S. González, A. Jiménez, F.
Sevilla, An extract from the plant Deschampsia antarctica protects fibroblasts
from senescence induced by hydrogen peroxide, Oxid. Med. Cell. Longev.
(2017)e2694945.
[39] L. Elbling, I. Herbacek, R.M. Weiss, C. Jantschitsch, M. Micksche, C. Gerner, H.
Pangratz, M. Grusch, S. Knasmüller, W. Berger, Hydrogen peroxide mediates
EGCG-induced antioxidant protection in human keratinocytes, Free Radic.
Biol. Med. 49 (2010) 1444–1452.
[40] T. Jin, M.J. Kim, W.I. Heo, K.Y. Park, S.Y. Choi, M.K. Lee, S.P. Hong, S.J. Kim, M. Im,
N.J. Moon, S.J. Seo, Adiponectin corrects premature cellular senescence and
normalizes antimicrobial peptide levels in senescent keratinocytes, Biochem.
Biophys. Res. Commun. 477 (2016) 678–684.
[41] M. Jurzak, K. Adamczyk, Influence of genistein on c-Jun, c-Fos and Fos-B of AP-
1 subunits expression in skin keratinocytes, fibroblasts and keloid fibroblasts
cultured in vitro, Acta Pol. Pharm. 70 (2013) 205–213.
[42] B. Poljsak, R.G. Dahmane, A. Godic, Intrinsic skin aging: the role of oxidative
stress, Acta Dermatovenerol. Alp. Panon. Adriat. 21 (2012) 33–36.
[43] A. Kammeyer, R.M. Luiten, Oxidation events and skin aging, Ageing Res. Rev. 21
(2015) 16–29.
[44] C. Quan, M.K. Cho, D. Perry, T. Quan, Age-associated reduction of cell spreading
induces mitochondrial DNA common deletion by oxidative stress in human
P. Savoia et al. / Journal of Dermatological Science 92 (2018) 62–77 77skin dermal fibroblasts: implication for human skin connective tissue aging, J.
Biomed. Sci. 22 (July) (2015) 62.
[45] K. Tsukahara, H. Nakagawa, S. Moriwaki, S. Kakuo, A. Ohuchi, Y. Takema, G.
Imokawa, Ovariectomy is sufficient to accelerate spontaneous skin ageing and
to stimulate ultraviolet irradiation-induced photoageing of murine skin, Br. J.
Dermatol. 151 (2004) 984–994.
[46] D. Cerimele, L. Celleno, F. Serri, Physiological changes in ageing skin, Br. J.
Dermatol. 122 (1990) 13–20.
[47] S. Stevenson, J. Thornton, Effect of estrogens on skin aging and the potential
role of SERMs, Clin. Interv. Aging 2 (2007) 283–297.
[48] (a) M.A. Weinstock, Epidemiologic investigation of nonmelanoma skin cancer
mortality: the Rhode Island Follow-Back Study, J. Invest. Dermatol. 102 (1994)
6S–9S;
(b) J.G. Miller, S. Mac Neil, Gender and cutaneous melanoma, Br. J. Dermatol.
136 (1997) 657–665.
[49] H. Polito, A. Marini, A. Bitto, N. Irrera, M. Vaccaro, E.B. Adamo, A. Micali, F.
Squadrito, L. Minutoli, D. Altavilla, Genistein aglycone, a soy-derived
isoflavone, improves skin changes induced by ovariectomy in rats, Br. J.
Pharmacol. 165 (2012) 994–1005.
[50] G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, P.T. van der Saag, B.
van der Burg, J.A. Gustafsson, Interaction of estrogenic chemicals and
phytoestrogens with estrogen receptor beta, Endocrinology. 139 (1998) 4252–
4263.
[51] T. Itagaki, I. Shimizu, X. Cheng, Y. Yuan, A. Oshio, K. Tamaki, H. Fukuno,
H. Honda, Y. Okamura, S. Ito, Opposing effects of oestradiol and progesterone
on intracellular pathways and activation processes in the oxidative stress
induced activation of cultured rat hepatic stellate cells, Gut 54 (2005) 1782–
1789.
[52] C.A. Chrestensen, J.L. McMurry, J.C. Salerno, MAP kinases bind endothelial
nitric oxide synthase, FEBS Open Bio 2 (February) (2012) 51–55, doi:http://dx.
doi.org/10.1016/j.fob.2012.02.002.
[53] B.J. Michel, Z.P. Chen, T. Tiganis, D. Stapleto, F. Katsis, D.A. Power, A.T. Sim, B.E.
Kemp, iNOS expression requires NADPH oxidase-dependent redox signaling in
microvascular endothelial cells, J. Cell. Physiol. 217 (October (1)) (2008) 207–
214, doi:http://dx.doi.org/10.1002/jcp.21495.
[54] F. Wu, K. Tym, J.X. Wilson, Coordinated control of endothelial nitric-oxide
synthase phosphorylation by protein kinase C and the cAMP-dependent
protein kinase, J. Biol. Chem. 276 (May (21)) (2001) 17625–17628 Epub 2001
Apr 5.[55] S. Shimizu, M. Ishii, T. Yamamoto, K. Momose, Mechanism of nitric oxide
production induced by H2O2 in cultured endothelial cells, Res. Commun. Mol.
Pathol. Pharmacol. 95 (March (3)) (1997) 227–239.
[56] J. Duarte, V. Francisco, F. Perez-Vizcaino, Modulation of nitric oxide by
flavonoids, Food Funct. 5 (August (8)) (2014) 1653–1668.
[57] G.C. Kujoth, A. Hiona, T.D. Pugh, S. Someya, K. Panzer, S.E. Wohlgemuth, T.
Hofer, A.Y. Seo, R. Sullivan, W.A. Jobling, J.D. Morrow, H. Van Remmen, J.M.
Sedivy, T. Yamasoba, M. Tanokura, R. Weindruch, C. Leeuwenburgh, T.A. Prolla,
Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian
aging, Science 309 (2005) 481–484.
[58] C. Borras, J. Sastre, D. Garcia-Sala, A. Lloret, F.V. Pallardo, J. Vina, Mitochondria
from females exhibit higher antioxidant gene expression and lower oxidative
damage than males, Free Radic. Biol. Med. 34 (2003) 546–552.
[59] J. Sastre, C. Borras, D. Garcia-Sala, A. Lloret, F.V. Pallardo, J. Vina, Mitochondrial
damage in aging and apoptosis, Ann. N. Y. Acad. Sci. 959 (2002) 448–451.
[60] R. Okuyama, H. Tagami, S. Aiba, Notch signaling: its role in epidermal
homeostasis and in the pathogenesis of skin diseases, J. Dermatol. Sci. 49
(March (3)) (2008) 187–194 Epub 2007 Jul 10.
[61] J. Carnesecchi, M. Malbouyres, R. de Mets, M. Balland, G. Beauchef, K. Vié, C.
Chamot, C. Lionnet, F. Ruggiero, J.M. Vanacker, Estrogens induce rapid
cytoskeleton re-organization in human dermal fibroblasts via the non-
classical receptor GPR30, PLoS One 10 (2015)e0120672.
[62] J. Ju, J. Wu, R. Hou, Role of the p38 mitogen-activated protein kinase signaling
pathway in estrogen-mediated protection following flap ischemia-reperfusion
injury, Cell Biochem. Funct. 34 (2016) 522–530.
[63] T.T. Huynh, K.S. Chan, T.J. Piva, Effect of ultraviolet radiation on the expression
of pp38MAPK and furin in human keratinocyte-derived cell lines,
Photodermatol. Photoimmunol. Photomed. 25 (2009) 20–29.
[64] E.E. Ayli, S. Dugas-Breit, W. Li, C. Marshall, L. Zhao, M. Meulener, T. Griffin, J.M.
Gelfand, J.T. Seykora, Curcuminoids activate p38 MAP kinases and promote
UVB-dependent signalling in keratinocytes, Exp. Dermatol.19 (2010) 493–500.
[65] F.K. Marcondes, F.J. Bianchi, A.P. Tanno, Determination of the estrous cycle
phases of rats: some helpful considerations, Braz. J. Biol. 62 (2002) 609–614.
[66] S.M. Kang, S. Han, J.H. Oh, Y.M. Lee, C.H. Park, C.Y. Shin, D.H. Lee, J.H. Chung, A
synthetic peptide blocking TRPV1 activation inhibits UV-induced skin
responses, J. Dermatol. Sci. 88 (2017) 126–133.
[67] J. Shin, J.E. Kim, K.J. Pak, J.I. Kang, T.S. Kim, S.Y. Lee, I.H. Yeo, J.K. Park, J.H. Kim, N.
J. Kang, K.W. Lee, A combination of soybean and haematococcus extract
alleviates ultraviolet B-induced photoaging, Int. J. Mol. Sci. 18 (2017), doi:
http://dx.doi.org/10.3390/ijms18030682 pii: E682.
